Amin Mirhadi, MD, is an assistant professor at Cedars-Sinai Medical Center in Los Angeles, California, where he is the ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points ...

However, quitting smoking lowers the risks of at least 12 different types of cancer, including cancers of the lung, liver, and esophagus. The longer an individual remains smoke free, the more their ...

“Decision-making is a critical component of health care delivery, but the number of therapies available can be overwhelming to patients, preventing them from making fully informed care decisions,” the ...

The editor in chief of Evidence-Based Oncology lauds Congress' authorization of a path for Medicare coverage for multicancer early detection. As this issue of Evidence-Based Oncology (EBO) went to ...

In this interview with the study’s lead author, Sarah M. Lima, PhD, MPH, an epidemiologist and postdoctoral fellow in cancer populations at the Georgetown Lombardi Comprehensive Cancer Center, she ...

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care ...

Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.